Back to VIKING GLOBAL INVESTORS LP

BBIO
Showing 8 of 28 quarters

Position history for VIKING GLOBAL INVESTORS LP's holdings in BRIDGEBIO PHARMA INC

VIKING GLOBAL INVESTORS LP holds 11.8M shares of BBIO (BRIDGEBIO PHARMA INC), worth $879.4M as of 2026-Q1. The position was decreased (-17.7% shares). BBIO represents 2.5% of VIKING GLOBAL INVESTORS LP's portfolio.

Current Value

$879.4M

Current Shares

11.8M

Total Value Change

+$243.1M

Total Shares Change

-13.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
11.8M
-17.7%
$879.4M2.5%$64.53
0
2025-Q4
Decreased
14.4M
-9.9%
$1.1B2.9%$75.48
0
2025-Q3
Decreased
16M
-13.9%
$829.9M2.2%$51.96
0
2025-Q2
Decreased
18.6M
-15.9%
$801.2M2.3%$44.86
0
2025-Q1
Decreased
22.1M
-12.2%
$762.5M2.4%$35.11
0
2024-Q4
Unchanged
25.1M
0.0%
$689.3M2.2%$27.32
0
2024-Q3
Unchanged
25.1M
0.0%
$639.6M2.3%$24.94
0
2024-Q2
Unchanged
25.1M
0.0%
$636.3M2.4%$25.33
0

Other major holders of BBIO: VANGUARD GROUP INC, BlackRock, Inc., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used